 |
| |
 |
| |
 |
| |
 |
| |
 |
Cardioxyl's first drug program focuses on nitroxyl (HNO) donors and their
potential for the intravenous treatment of acute decompensated heart failure
(ADHF).
About Acute Decompensated Heart Failure (ADHF)
potential for the intravenous treatment of acute decompensated heart failure
(ADHF).
About Acute Decompensated Heart Failure (ADHF)
| Copyright 2007 Cardioxyl Pharmaceuticals, Inc. All rights reserved. |